Citation Impact
Citing Papers
Fetal Hemoglobin, Sickling, and Sickle Cell Disease
1990
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice
2003
Vibrio vulnificus Septicemia in a Patient With the Hemochromatosis HFE C282Y Mutation
2001
Behavior of Infants with Iron-Deficiency Anemia
1998
How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria
2005
Liver Gene Expression During Chronic Dietary Iron Overload in Rats
1990
Experimental liver cirrhosis induced by alcohol and iron.
1995
Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94
1994
Tolerability of different oral iron supplements: a systematic review
2012
Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations
1992
Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice
1999
Nutritional immunity: transition metals at the pathogen–host interface
2012 Standout
The β-Thalassemias
1999 Standout
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
1995 Standout
Evaluation of iron overload
2004
Nonalcoholic Fatty Liver Disease
2002 Standout
Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major
1994
Iron increases ethanol toxicity in rat liver
1993
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The hereditary hemochromatosis gene (HFE)
1999
Regulatory Interactions between Iron and Nitric Oxide Metabolism for Immune Defense againstPlasmodium falciparumInfection
2001
Morphologic Observations in Iron Overload: An Update
1994
Nitric oxide synthases: Roles, tolls, and controls
1994 Standout
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Liver iron depletion and toxicity of the iron chelator Deferiprone (L, CP20) in the guinea pig
1997
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
1995
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Design of iron chelators with therapeutic application
2012
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents
1998
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Enhanced γ-Glutamyl Transpeptidase Expression and Selective Loss of CuZn Superoxide Dismutase in Hepatic Iron Overload
1998
Iron Chelators for Thalassaemia
1998
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Iron-induced oxidant stress in alcoholic liver fibrogenesis
2003
Microfluidic organs-on-chips
2014 Standout
Seeking Candidate Mutations That Affect Iron Homeostasis
2002
Iron toxicity and antioxidant nutrients
2002
Sickle Cell Hemoglobin Polymerization
1990
Liver fibrosis in genetic hemochromatosis
1992
Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents.
1995
A Risk-Benefit Assessment of Iron-Chelation Therapy
1997
A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload
2001 Standout
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis
1994
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Diagnosis and Management of Iron Deficiency Anemia
2014
Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease
1988
Sickle-cell disease
2010 Standout
Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload.
1990
The effect of lead exposure on behavior problems in preschool children.
1998
Oxidative mechanisms in the toxicity of metal ions
1995 Standout
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
2004
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
The present and future role of microfluidics in biomedical research
2014 StandoutNature
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Photodynamic therapy of cancer: An update
2011 Standout
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
2008 Standout
Homology requirements for unequal crossing over in humans.
1991 StandoutNobel
Child development: risk factors for adverse outcomes in developing countries
2007 Standout
5 Thalassaemia: clinical management
1998
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major
1998
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Disorders of Iron Metabolism
1999 Standout
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 Standout
The Human Condition—A Molecular Approach
2014 StandoutNobel
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Prevention of iron deficiency and psychomotor decline in high-risk infants through use of iron-fortified infant formula: A randomized clinical trial
1994
Chemistry and biology of eukaryotic iron metabolism
2001
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
1993 Standout
Anemia of Chronic Disease
2005 Standout
Intellectual Impairment in Children with Blood Lead Concentrations below 10 μg per Deciliter
2003 Standout
Extended Therapy with Intravenous Arginine Butyrate in Patients with β-Hemoglobinopathies
1995
Pulmonary Complications of Sickle Cell Disease
2012
Superinfection in malaria: Plasmodium shows its iron will
2011
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Nitric oxide and the immune response
2001 Standout
Enantioselective Synthesis of Di- and Tri-Arylated All-Carbon Quaternary Stereocenters via Copper-Catalyzed Allylic Arylations with Organolithium Compounds
2016 StandoutNobel
Distribution of Transferrin Saturations in the African-American Population
1998
Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo
1995
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
2006 Standout
Management of Hemochromatosis
1998
Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex
1991
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
2003 Standout
The Heme Oxygenase Dilemma in Cellular Homeostasis: New Insights for the Feedback Regulation of Heme Catabolism
2003
Vibrio vulnificus septicemia in a patient with the hemochromatosis HFE C282Y mutation.
2001
The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes
1987
Carbonyl iron for short‐term supplementation in female blood donors
1987
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.
1999
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Hemoglobin S gelation and sickle cell disease
1987
A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
2012
Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats
2000
Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow.
1987
Iron regulates nitric oxide synthase activity by controlling nuclear transcription.
1994
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors
2014
31P-Magnetization Transfer Magnetic Resonance Spectroscopy Measurements of In Vivo Metabolism
2012
Iron-Deficiency Anemia
2015 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Iron Release From Human Monocytes After Erythrophagocytosis In Vitro: An Investigation in Normal Subjects and Hereditary Hemochromatosis Patients
1998
A mouse model for beta 0-thalassemia.
1995 StandoutNobel
The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
1998
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models.
2000 Standout
Iron overload diminishes atherosclerosis in apoE-deficient mice
2001
Works of GM Brittenham being referenced
Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating site
1993
Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes
1985
Uniformity of liver density and nonheme (storage) iron distribution.
1987
Clinical Consequences of New Insights in the Pathophysiology of Disorders of Iron and Heme Metabolism
2000
Transferrin saturation and recovery from coma in cerebral malaria
1995
Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
1990
Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes
1985
Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia [see comments]
1992
Prevalence of heterozygotes for hemochromatosis in the white population of the United States
1995
Development of iron-chelating agents for clinical use [editorial; comment]
1992
High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial
1987
Development of iron-chelating agents for clinical use [editorial; comment]
1992
The synergistic effects of vitamin E and selenium in iron-overloaded mouse hearts.
1998
Behavioral aspects of iron deficiency.
1986
Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia [see comments]
1992
Decreased concentrations of tumor necrosis factor-alpha in supernatants of monocytes from homozygotes for hereditary hemochromatosis
1992
Pathology of dietary carbonyl iron overload in rats.
1987
Carbonyl iron therapy for iron deficiency anemia
1986